The objective of this proposal is the development of surrogate tissue controls for clinical immunohistochemical (IHC) assays. Presently, each clinical histology laboratory identifies, sections, validates, and archives their own tissue controls. This method is labor-intensive, non-standard, and does not detect either early reagent failure or procedure error. In the Phase I study, we developed synthetic controls for two of the most important analytes in the IHC laboratory - - estrogen and progesterone receptors (ER/PR). Our """"""""synthetic"""""""" controls are (1) inexpensive, (2) antigen-specific, (3) available in an inexhaustible supply, (4) standardized, (5) stable, for ease of storage, and (6) quantifiable, for providing a reference standard against which to measure assay sensitivity. The Phase II specific aims include: (1) Clinical Validation, leading to FDA clearance for the ER/PR controls, and (2) Development of a complete panel of analyte controls. The first specific aim defines the product's clinical utility.
The second aim i s an extension of our Phase I technology. We will finish the task started in Phase I, to create a panel of synthetic controls that meet the clinical laboratories' quality control needs. These synthetic controls are a unique tool to verify proper assay performance and minimize analytic error.

Proposed Commercial Applications

The technology described in this grant proposal will provide the first commercially produced, standardized quality control system for clinical immunohistochemical assays. Controls are important to ensure that a patient's test result is accurate, regardless of which laboratory performs the test.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44CA081950-02
Application #
6142517
Study Section
Special Emphasis Panel (ZRG1-SSS-4 (02))
Program Officer
Song, Min-Kyung H
Project Start
1999-04-01
Project End
2002-03-30
Budget Start
2000-04-14
Budget End
2001-03-31
Support Year
2
Fiscal Year
2000
Total Cost
$737,434
Indirect Cost
Name
Cytologix Corporation
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Vani, Kodela; Bogen, Steven A; Sompuram, Seshi R (2006) A high throughput combinatorial library technique for identifying formalin-sensitive epitopes. J Immunol Methods 317:80-9
Sompuram, Seshi R; Vani, Kodela; Messana, Elizabeth et al. (2004) A molecular mechanism of formalin fixation and antigen retrieval. Am J Clin Pathol 121:190-9
Bogen, Steven A; Sompuram, Seshi R (2004) Recent trends and advances in immunodiagnostics of solid tumors. BioDrugs 18:387-98
Sompuram, Seshi R; Vani, Kodela; Wei, Lan et al. (2004) A water-stable protected isocyanate glass array substrate. Anal Biochem 326:55-68
Sompuram, Seshi R; Kodela, Vani; Ramanathan, Halasya et al. (2002) Synthetic peptides identified from phage-displayed combinatorial libraries as immunodiagnostic assay surrogate quality-control targets. Clin Chem 48:410-20